Product Reports Resources Pricing Login Book a demo

La Renon

Biotech & Life Sciences · Ahmedabad, India · Founded 2007

Producing and distributing medicines for chronic and critical illnesses

Talent graph

La Renon's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on La Renon's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
A91 Partners
Sequoia
Series B+ 4 investors entered at this stage
WhiteOak Capital Asset Management
Creador
Avendus Capital
Siguler Guff & Company

Ownership

Who owns La Renon

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

64% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where La Renon has talent and traffic

Workforce by country
7 countries with
team presence
🇮🇳 India97.6%
🇳🇵 Nepal0.8%
🇰🇪 Kenya0.5%
🇬🇧 United Kingdom0.4%
🇰🇭 Cambodia0.4%
Top 5 of 7 shown
Web traffic by country
20K monthly visits
across markets
🇮🇳 India90%
🇺🇸 United States8.5%
Top 2 markets shown

Market sentiment

What the market is saying about La Renon

An AI-synthesized read of the highest-engagement posts about La Renon on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See La Renon on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.